ADIM
NXGN

Alpha DNA Investment Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Alpha DNA Investment Management’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-60,354
Closed -$1.05M – 226
2023
Q1 		$1.05M Buy
+60,354
New +$1.08M 0.31% 102
2021
Q2 		– Sell
-262
Closed -$4K – 709
2021
Q1 		$4K Buy
+262
New +$5.17K ﹤0.01% 435

Other funds holding NXGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's NXGN Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q2 2023, closing a stake of 60,354 shares — an estimated $1.05M sold.

Alpha DNA Investment Management first reported a position in NXGN in Q1 2021 and held it in 2 quarters. The position peaked at $1.05M in Q1 2023. 207 funds tracked by Wall St. Rank hold NXGN as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 60,354 NextGen Healthcare, Inc. Common Stock shares in Q2 2023, an estimated $1.05M.
  • Alpha DNA Investment Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Alpha DNA Investment Management's NextGen Healthcare, Inc. Common Stock position peaked at $1.05M in Q1 2023.
  • 207 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.